Shopping Cart
Remove All
Your shopping cart is currently empty
URAT1-IN-14 is a potent and orally active inhibitor of uric acid transporter 1 (URAT1). It demonstrates an IC50 value of 0.72 μM for inhibiting human URAT1 in HEK293 cells and exhibits low cytotoxicity in Hep-G2 cells. URAT1-IN-14 reduces uric acid levels in a hyperuricemia mouse model and is applicable in research on hyperuricemia and gout.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | URAT1-IN-14 is a potent and orally active inhibitor of uric acid transporter 1 (URAT1). It demonstrates an IC50 value of 0.72 μM for inhibiting human URAT1 in HEK293 cells and exhibits low cytotoxicity in Hep-G2 cells. URAT1-IN-14 reduces uric acid levels in a hyperuricemia mouse model and is applicable in research on hyperuricemia and gout. |
| In vitro | URAT1-IN-14 (Compound 7) exhibits lower cytotoxicity to Hep-G2 cells (IC 50 = 326.5 μM) compared to Benzbromarone (IC 50 = 67.21 μM). |
| In vivo | URAT1-IN-14 (Compound 7) administered orally at 25-100 mg/kg as a single dose or over 9 consecutive days significantly reduces blood uric acid levels in subacute and chronic hyperuricemic mouse models, demonstrating effects comparable to Benzbromarone. |
| Molecular Weight | 341.42 |
| Formula | C19H19NO3S |
| Cas No. | 2516232-89-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.